Protein production

This article is about the biotechnological method. For the natural process in cells, see Gene expression.
Central dogma depicting transcription from DNA code to RNA code to the proteins in the second step covering the production of protein.
Central dogma depicting transcription from DNA code to RNA code to the proteins in the second step covering the production of protein.

Protein production is the biotechnological process of generating a specific protein. It is typically achieved by the manipulation of gene expression in an organism such that it expresses large amounts of a recombinant gene. This includes the transcription of the recombinant DNA to messenger RNA (mRNA), the translation of mRNA into polypeptide chains, which are ultimately folded into functional proteins and may be targeted to specific subcellular or extracellular locations.[1]

Protein production systems (in lab jargon also referred to as 'expression systems') are used in the life sciences, biotechnology, and medicine. Molecular biology research uses numerous proteins and enzymes, many of which are from expression systems; particularly DNA polymerase for PCR, reverse transcriptase for RNA analysis, restriction endonucleases for cloning, and to make proteins that are screened in drug discovery as biological targets or as potential drugs themselves. There are also significant applications for expression systems in industrial fermentation, notably the production of biopharmaceuticals such as human insulin to treat diabetes, and to manufacture enzymes.

Protein production systems

Commonly used protein production systems include those derived from bacteria,[2] yeast,[3][4]baculovirus/insect,[5] mammalian cells,[6][7] and more recently filamentous fungi such as Myceliophthora thermophila.[8]

Cell-based systems

The oldest and most widely used expression systems are cell-based and may be defined as the "combination of an expression vector, its cloned DNA, and the host for the vector that provide a context to allow foreign gene function in a host cell, that is, produce proteins at a high level".[9][10] Expression may be done to a high level, referred to as overexpression.

There are many ways to introduce foreign DNA to a cell for expression, and many different host cells may be used for expression — each expression system has distinct advantages and liabilities. Expression systems are normally referred to by the host and the DNA source or the delivery mechanism for the genetic material. For example, common hosts are bacteria (such as E.coli, B. subtilis), yeast (such as S.cerevisiae[4]) or eukaryotic cell lines. Common DNA sources and delivery mechanisms are viruses (such as baculovirus, retrovirus, adenovirus), plasmids, artificial chromosomes and bacteriophage (such as lambda). The best expression system depends on the gene involved, for example the Saccharomyces cerevisiae is often preferred for proteins that require significant posttranslational modification. Insect or mammal cell lines are used when human-like splicing of mRNA is required. Nonetheless, bacterial expression has the advantage of easily producing large amounts of protein, which is required for X-ray crystallography or nuclear magnetic resonance experiments for structure determination.

Because bacteria are prokaryotes, they are not equipped with the full enzymatic machinery to accomplish the required post-translational modifications or molecular folding. Hence, multi-domain eukaryotic proteins expressed in bacteria often are non-functional. Also, many proteins become insoluble as inclusion bodies that are difficult to recover without harsh denaturants and subsequent cumbersome protein-refolding.

To address these concerns, expressions systems using multiple eukaryotic cells were developed for applications requiring the proteins be conformed as in, or closer to eukaryotic organisms: cells of plants (i.e. tobacco), of insects or mammalians (i.e. bovines) are transfected with genes and cultured in suspension and even as tissues or whole organisms, to produce fully folded proteins. Mammalian in vivo expression systems have however low yield and other limitations (time-consuming, toxicity to host cells,..). To combine the high yield/productivity and scalable protein features of bacteria and yeast, and advanced epigenetic features of plants, insects and mammalians systems, other protein production systems are developed using unicellular eukaryotes (i.e. non-pathogenic 'Leishmania' cells).

Bacterial systems

Escherichia coli
E. coli, one of the most popular hosts for artificial gene expression.

E. coli is one of the most widely used expression hosts, and DNA is normally introduced in a plasmid expression vector. The techniques for overexpression in E. coli are well developed and work by increasing the number of copies of the gene or increasing the binding strength of the promoter region so assisting transcription.

For example, a DNA sequence for a protein of interest could be cloned or subcloned into a high copy-number plasmid containing the lac promoter, which is then transformed into the bacterium E. coli. Addition of IPTG (a lactose analog) activates the lac promoter and causes the bacteria to express the protein of interest.

Corynebacterium

Non-pathogenic species of the gram-positive Corynebacterium are used for the commercial production of various amino acids. The C. glutamicum species is widely used for producing glutamate and lysine,[11] components of human food, animal feed and pharmaceutical products.

Expression of functionally active human epidermal growth factor has been done in C. glutamicum,[12] thus demonstrating a potential for industrial-scale production of human proteins. Expressed proteins can be targeted for secretion through either the general, secretory pathway (Sec) or the twin-arginine translocation pathway (Tat).[13]

Unlike gram-negative bacteria, the gram-positive Corynebacterium lack lipopolysaccharides that function as antigenic endotoxins in humans.

Pseudomonas fluorescens

The non-pathogenic and gram-negative bacteria, Pseudomonas fluorescens, is used for high level production of recombinant proteins; commonly for the development bio-therapeutics and vaccines. P. fluorescens is a metabolically versatile organism, allowing for high throughput screening and rapid development of complex proteins. P. fluorescens is most well known for its ability to rapid and successfully produce high titers of active, soluble protein.[14]

Eukaryotic systems

Saccharomyces cerevisiae, Pichia Pastoris

Expression systems in yeast typically use the common and well known S. cerevisiae, but also Bacillus sp. Systems using Pichia pastoris allow stable and lasting production of proteins closer to mammalian cells, at high yield, in chemically defined media of proteins.

Filamentous fungi

Filamentous fungi, especially Aspergillus and Trichoderma, but also more recently Myceliophthora thermophila C1[8] have been developed into expression platforms for screening and production of diverse industrial enzymes. The expression system C1 shows a low viscosity morphology in submerged culture, enabling the use of complex growth and production media.

Baculovirus-infected cells

Infected insect cells[15] (Sf9, Sf21, High Five strains) or mammalian cells[16] (HeLa, HEK 293) allow production of glycosylated or membrane proteins that cannot be expressed using yeast or prokaryotic cells (E. coli).[17] It is useful for production of proteins in high quantity. Genes are not expressed continuously because infected host cells eventually lyse and die during each infection cycle.[18]

Non-lytic insect cell expression

Non-lytic insect cell expression is an alternative to the lytic baculovirus expression system. In non-lytic expression, vectors are transiently or stably transfected into the chromosomal DNA of insect cells for subsequent gene expression.[19][20] This is followed by selection and screening of recombinant clones.[21] The non-lytic system has been used to give higher protein yield and quicker expression of recombinant genes compared to baculovirus-infected cell expression.[20] Cell lines used for this system include: Sf9, Sf21 from Spodoptera frugiperda cells, Hi-5 from Trichoplusia ni cells, and Schneider 2 cells and Schneider 3 cells from Drosophila melanogaster cells.[19][21] With this system, cells do not lyse and several cultivation modes can be used.[19] Additionally, protein production runs are reproducible.[19][20] This system gives a homogeneous product.[20] A drawback of this system is the requirement of an additional screening step for selecting viable clones.[21]

Leishmania

Protozoan Leishmania tarentolae (non-pathogenic strain) expression systems allow stable and lasting production of proteins at high yield, in chemically defined media. Produced proteins exhibit fully eukaryotic post-translational modifications, including glycosylation and disulfide bond formation.

Mammalian systems

The most common mammalian expression systems are Chinese Hamster ovary (CHO) and Human embryonic kidney (HEK) cells.[22][23][24]

Cell-free systems

Cell-free production of proteins is performed in vitro using purified RNA polymerase, ribosomes, tRNA and ribonucleotides. These reagents may be produced by extraction from cells or from a cell-based expression system. Due to the low expression levels and high cost of cell-free systems, cell-based systems are more widely used.[26]

See also

References

  1. ↑ Gräslund, Susanne; et al. (February 2008). "Protein production and purification". Nature Methods. 5 (2): 135–146. doi:10.1038/nmeth.f.202.
  2. ↑ Baneyx F (October 1999). "Recombinant protein expression in Escherichia coli". Curr. Opin. Biotechnol. 10 (5): 411–21. doi:10.1016/s0958-1669(99)00003-8. PMID 10508629.
  3. ↑ Cregg JM, Cereghino JL, Shi J, Higgins DR (September 2000). "Recombinant protein expression in Pichia pastoris". Mol. Biotechnol. 16 (1): 23–52. doi:10.1385/MB:16:1:23. PMID 11098467.
  4. 1 2 Malys N, Wishart JA, Oliver SG, McCarthy JE (2011). "Protein production in Saccharomyces cerevisiae for systems biology studies". Methods Enzymol. 500: 197–212. doi:10.1016/B978-0-12-385118-5.00011-6. PMID 21943899.
  5. ↑ Kost TA, Condreay JP, Jarvis DL (May 2005). "Baculovirus as versatile vectors for protein expression in insect and mammalian cells". Nat. Biotechnol. 23 (5): 567–75. doi:10.1038/nbt1095. PMID 15877075.
  6. ↑ Rosser MP, Xia W, Hartsell S, McCaman M, Zhu Y, Wang S, Harvey S, Bringmann P, Cobb RR (April 2005). "Transient transfection of CHO-K1-S using serum-free medium in suspension: a rapid mammalian protein expression system". Protein Expr. Purif. 40 (2): 237–43. doi:10.1016/j.pep.2004.07.015. PMID 15766864.
  7. ↑ Lackner A, Genta K, Koppensteiner H, Herbacek I, Holzmann K, Spiegl-Kreinecker S, Berger W, Grusch M (September 2008). "A bicistronic baculovirus vector for transient and stable protein expression in mammalian cells". Anal. Biochem. 380 (1): 146–8. doi:10.1016/j.ab.2008.05.020. PMID 18541133.
  8. 1 2 Visser, Hans; Joosten, Vivi; Punt, Peter J.; Gusakov, Alexander V.; Olson, Phil T.; Joosten, Rob; Bartels, Jeffrey; Visser, Jaap; Sinitsyn, Arkady P. (2011-06-01). "RESEARCH: Development of a mature fungal technology and production platform for industrial enzymes based on a Myceliophthora thermophila isolate, previously known as Chrysosporium lucknowense C1". Industrial Biotechnology. 7 (3): 214–223. doi:10.1089/ind.2011.7.214. ISSN 1550-9087.
  9. ↑ "Definition: expression system". Online Medical Dictionary. Centre for Cancer Education, University of Newcastle upon Tyne: Cancerweb. 1997-11-13. Retrieved 2008-06-10.
  10. ↑ "Expression system - definition". Biology Online. Biology-Online.org. 2005-10-03. Retrieved 2008-06-10.
  11. ↑ Brinkrolf, K; Schröder, J; Pühler, A; Tauch, A (2010). "The transcriptional regulatory repertoire of Corynebacterium glutamicum: reconstruction of the network controlling pathways involved in lysine and glutamate production". J Biotechnol. 149 (3): 173–82. doi:10.1016/j.jbiotec.2009.12.004.
  12. ↑ Date, M; Yokoyama, K; Umezawa, Y; Matsui, H; Kikuchi, Y (2006). "Secretion of human epidermal growth factor by Corynebacterium glutamicum". Lett Appl Microbiol. 42 (1): 66–70. doi:10.1111/j.1472-765x.2005.01802.x.
  13. ↑ Meissner, D; Vollstedt, A; van Dijl, JM; Freudl, R (2007). "Comparative analysis of twin-arginine (Tat)-dependent protein secretion of a heterologous model protein (GFP) in three different Gram-positive bacteria". Appl Microbiol Biotechnol. 76 (3): 633–42. doi:10.1007/s00253-007-0934-8.
  14. ↑ Retallack, Jin, Chew (2011). "Reliable Protein Production in a Pseudomonas fluorescens Expression System." Protein Expression and Purification 2011; 81 : 157-65.
  15. ↑ Altmann, Friedrich; Staudacher, E; Wilson, IB; März, L (1999). "Insect cells as hosts for the expression of recombinant glycoproteins". Glycoconjugate Journal. 16 (2): 109–23. doi:10.1023/A:1026488408951. PMID 10612411.
  16. ↑ Kost, T; Condreay, JP (1999). "Recombinant baculoviruses as expression vectors for insect and mammalian cells". Current Opinion in Biotechnology. 10 (5): 428–33. doi:10.1016/S0958-1669(99)00005-1. PMID 10508635.
  17. ↑ Altmann, Friedrich; Staudacher, Erika; Wilson, Iain B. H.; März, Leopold. "Insect cells as hosts for the expression of recombinant glycoproteins". Glycoconjugate Journal. 16 (2): 109–123. doi:10.1023/A:1026488408951. ISSN 0282-0080.
  18. ↑ Yin, Jiechao; Li, Guangxing; Rena, Xiaofeng; Herrler, Georg (2007). "Select what you need: A comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes". Journal of Biotechnology. 127: 335–347. doi:10.1016/j.jbiotec.2006.07.012.
  19. 1 2 3 4 Dyring, Charlotte (2011). "Optimising the drosophila S2 expression system for production of therapeutic vaccines". Bioprocessing Journal. 10: 28–35. doi:10.12665/j102.dyring.
  20. 1 2 3 4 Olczak, Mariusz; Olczak, Teresa (2006). "Comparison of different signal peptides for protein secretion in nonlytic insect cell system". Analytical Biochemistry. 359: 45–53. doi:10.1016/j.ab.2006.09.003.
  21. 1 2 3 McCarroll, L.; King, L.A. (1997). "Stable insect culture for recombinant protein production". Current Opinions in Biotechnology. 8: 590–594. doi:10.1016/s0958-1669(97)80034-1.
  22. ↑ Zhu, Jianwei (2012-09-01). "Mammalian cell protein expression for biopharmaceutical production". Biotechnology Advances. 30 (5): 1158–1170. doi:10.1016/j.biotechadv.2011.08.022.
  23. 1 2 3 4 Almo, Steven C; Love, James D (2014-06-01). "Better and faster: improvements and optimization for mammalian recombinant protein production". Current Opinion in Structural Biology. New constructs and expression of proteins / Sequences and topology. 26: 39–43. doi:10.1016/j.sbi.2014.03.006. PMC 4766836Freely accessible. PMID 24721463.
  24. ↑ Hacker, David L; Balasubramanian, Sowmya (2016-06-01). "Recombinant protein production from stable mammalian cell lines and pools". Current Opinion in Structural Biology. New constructs and expression of proteins • Sequences and topology. 38: 129–136. doi:10.1016/j.sbi.2016.06.005.
  25. ↑ Zhu, Jianwei (2012-09-01). "Mammalian cell protein expression for biopharmaceutical production". Biotechnology Advances. 30 (5): 1158–1170. doi:10.1016/j.biotechadv.2011.08.022.
  26. ↑ Rosenblum, G; Cooperman, BS (Jan 2014). "Engine out of the chassis: cell-free protein synthesis and its uses". FEBS Lett. 588 (2): 261–8. doi:10.1016/j.febslet.2013.10.016. PMID 24161673.

Further reading

Microorganisms
Microbiology
Ecology
Techniques
Marine
Human related
Other

This article is issued from Wikipedia - version of the 11/25/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.